"我们后台显示眼镜搜索量大涨。"近日，一家智能眼镜企业告诉记者，得益于2026年"国补"落地，消费者对智能眼镜的咨询量和关注度都极大提升。 去年底，国家发展改革委、财政部联合发布《关于2026年实施大规模设备更新和消费品以旧换新政策的通知》，其中，将数码产品购新补贴拓展为数码和 智能产品购新补贴，支持范围包括手机、平板、智能手表（手环）、智能眼镜和智能家居产品（含适老化家居产品）。这也是智能眼镜首次纳入"国补"， 与手机、平板等产品并列。 近日，记者在某电商平台的雷鸟智能眼镜旗舰店看到，多款眼镜都标注了"国补"价。比如爆款雷鸟 RayNeo Air 4 Pro智能AR眼镜头戴电视HDR10眼镜，原 价为3510元，叠加店铺优惠、"国补"后价格为1750.85元。"相当于领'国补'下单可以再省快100元。"店铺商家告诉记者。 在工信部信息通信经济专家委员会委员盘和林看来，当前，智能眼镜发展尚处于市场推广的早期，产品不成熟，用户规模小，这一政策是为了支持智能眼 镜产业的发展，也是为了通过"国补"打造一个智能眼镜制造研发产业链。"此举的确促进了智能眼镜产业的繁荣，让智能眼镜产品提早步入快速成长期， 迅速扩大对智能眼 ...

Group 1 - Apple launched a New Year discount event for its products on January 25, with significant price reductions for the iPhone Air and iPhone 17 series [1][4] - The iPhone Air, which was released just over three months ago, saw a total price drop of 2,500 yuan, now priced at 5,499 yuan after various discounts [1][4] - The discount event is exclusive to online platforms like Taobao and JD, with no participation from physical stores [4] Group 2 - The iPhone Air is facing challenges in the market as the first eSIM phone in China, with users finding the activation process cumbersome compared to traditional SIM cards [5] - IDC reported that the iPhone Air's sales were only about one-third of Apple's expectations, leading to a 50% reduction in its production plan shortly after launch [7] - Competitors like Huawei and Honor have started releasing their own lightweight models, such as the Huawei Mate70 Air and Honor Magic8 Pro Air, at significantly lower prices [7]

Core Viewpoint - Zhang Xiaoqin (301055) announced that shareholder Shanghai Tuyue Chengxiang Brand Management Partnership (Limited Partnership) will increase its stake in the company by 1.5 million shares between January 16 and January 20, 2026, making it the largest shareholder with a combined holding of 29.11% [1] Group 1: Shareholding Changes - Following the stake increase, the holding ratio of Tuyue Chengxiang and its concerted action party Rongquan Investment rose from 28.15% to 29.11%, and from 29% to 29.99% when excluding repurchased shares [1] - The change in shareholding resulted in the company's controlling shareholder shifting from Zhang Xiaoqin Group to no controlling shareholder, and the actual controllers changed from Zhang Guobiao, Zhang Zhangsheng, and Zhang Xincheng to no actual controller [1] Group 2: Funding Sources - The funding for the share purchase comes from self-raised funds, specifically a loan from Beijing Weilan Yongxu Technology Co., Ltd. to Tuyue Chengxiang, which will later convert into capital contributions [2] - The actual controller of Tuyue Chengxiang is Wang Aoyan, who also serves as a director and general manager of Zhang Xiaoqin, and has a background in various technology and management roles [2] Group 3: Financial Performance - Zhang Xiaoqin's net profit has declined for three consecutive years from 2022 to 2024, with a reported revenue of 908 million yuan in 2024, an increase of 11.87%, but a net profit of 25.04 million yuan, down 0.3% year-on-year [4] - In the latest performance report for the first three quarters of 2025, the company achieved a revenue of 726 million yuan, a year-on-year increase of 14.11%, and a net profit of 37.98 million yuan, up 120.78% [4] Group 4: Market Position - As of January 26, the stock price of Zhang Xiaoqin was 23.2 yuan per share, with a total market capitalization of 3.619 billion yuan [5]

嘉美包装（002969）（002969）1月25日公告，公司股票自2025年12月17日至2026年1月23日期间价格涨幅为408.11%，期间多次触及股票交易异常波动情 形，公司股票短期内价格涨幅较大，已背离公司基本面，为维护投资者利益，公司将就股票交易波动情况进行停牌核查。 经公司向深圳证券交易所申请，公司股票自2026年1月26日（星期一）开市起停牌，预计停牌时间不超过5个交易日。 公告称，嘉美包装股票最新市净率、市盈率显著高于行业平均水平，未来可能存在股价快速下跌的风险。截至2026年1月23日，公司股票静态市盈率 132.58，市净率9.61；公司所属金属制品业静态市盈率为44.61，市净率为3.24。公司股票市盈率和市净率与同行业情况存在显著差异，存在市场情绪过 热、非理性炒作风险。 值得一提的是，本月初公司已进行过一次停牌核查。嘉美包装1月6日晚间公告，公司股票自1月7日开市起停牌，预计不超过3个交易日。后公司股票于1月 12日开市起复牌。 在1月25日公告中，嘉美包装针对公司股票交易异常波动的情况，对有关事项进行了核实。 公司控股股东中国食品包装有限公司与苏州逐越鸿智科技发展合伙企业签署了《关 ...

Core Viewpoint - Huangshan Gujie (301581), a company listed on the ChiNext board for just over a year, has projected a significant decline in net profit for 2025, despite expected revenue growth, indicating a challenging financial outlook for the company [1][2]. Financial Performance - The company expects a net profit attributable to shareholders of 51 million to 61 million yuan for 2025, representing a year-on-year decline of 45.50% to 54.43% [1][2]. - The net profit after deducting non-recurring gains and losses is projected to be between 46 million and 55 million yuan, reflecting a decrease of 46.21% to 55.01% compared to the previous year [1][2]. - In the first three quarters of 2025, the company reported a revenue of 581 million yuan, a year-on-year increase of 20.42%, but the net profit was only 50.05 million yuan, down 44.60% [3]. - The net cash flow from operating activities for the first three quarters of 2025 was 12.96 million yuan, a sharp decline of 81.81% year-on-year, indicating deteriorating cash generation ability [3]. - The gross margin for the first three quarters of 2025 was 14.25%, a decrease of 10.74 percentage points from the previous year [3]. - The weighted average return on equity fell to 4.95%, down 14.07 percentage points year-on-year, and earnings per share dropped by 58.28% to 0.63 yuan [3]. Market Response - Since its listing, Huangshan Gujie has experienced a cumulative stock price decline of approximately 36%, with the latest share price at 49.07 yuan and a total market capitalization of 3.926 billion yuan [4]. - Investors have raised concerns regarding the continuous decline in stock price and have inquired about potential measures to boost shareholder confidence, such as agreements to restrict major shareholders from selling shares if performance targets are not met [4]. - The company has committed to reminding shareholders of their obligations regarding share sales and aims to enhance its core competitiveness and operational quality to improve long-term investment value [4].

1月25日晚间，新莱福（301323）发布公告称，公司拟向圣慈科技、广州易上、华农资产、金诚莱发行股份及支付现金购买其持有的广州金南磁性材料有 限公司(以下简称"金南磁材"或"标的公司")100%股权，交易金额为10.54亿元。本次交易完成后，金南磁材将成为公司的子公司。此外，公司拟向不超过 35名特定投资者募集配套资金，总额不超过4.8亿元。 据草案披露，交易对方圣慈科技、广州易上、金诚莱承诺标的公司业绩承诺期内(2025年度、2026年度和2027年度)净利润分别不低于8156.59万元、 8869.17万元及9414.08万元，如业绩承诺期为2026年度、2027年度及2028年度，则净利润分别不低于8869.17万元、9414.08万元及10036.54万元。 对此，新莱福称，业绩承诺期内若宏观经济、政策环境等外部因素发生变化，则可能给标的公司的经营管理造成不利影响。如果标的公司经营情况未达预 期，可能导致业绩承诺无法实现，进而影响上市公司的整体经营业绩和盈利水平。同时，尽管上市公司已经与承担业绩补偿责任的交易对方签订了明确的 补偿协议，但本次交易依然存在业绩补偿承诺实施的违约风险。 此外，标的公司面 ...

Core Viewpoint - The initial ruling by the U.S. International Trade Commission (ITC) found that the company's subsidiaries did not infringe on the patents claimed by Skyworks Solutions, allowing the company to continue exporting its products to the U.S. market [1][6]. Group 1: Legal Proceedings - On May 2024, Skyworks filed a patent infringement lawsuit against the company's subsidiary, claiming infringement of five patents related to specific RF front-end modules (FEMS) [4]. - The ITC issued a notice of investigation in August 2024, formally opening the case under Inv.No.337-TA-1413 [4]. - The ITC's administrative law judge issued a preliminary ruling on January 24, 2026, stating that the company did not violate Section 337 of the Tariff Act of 1930 [4][6]. Group 2: Patent Status - Three of the patents involved in the investigation (US 9,450,579, US 9,148,194, and US 7,409,200) were withdrawn by Skyworks during the evidence disclosure phase, terminating the investigation for those patents [5]. - The company has not infringed on any of the five patents claimed by Skyworks [6]. Group 3: Business Implications - A favorable ruling in the 337 investigation would allow the company's products to continue entering the U.S. market, strengthening its market share and industry influence [6][9]. - The outcome of the investigation will not directly affect the company's operations in markets outside the U.S. due to the territorial nature of patents [7][9]. - The 337 investigation does not involve monetary damages, and any litigation costs will cease following the final ruling, indicating no significant legal expenses for 2026 [7][9]. Group 4: Company Performance - For the first three quarters of 2025, the company reported total revenue of 526 million yuan, a year-on-year increase of 39.32%, but incurred a net loss of 30.53 million yuan [10]. - The company faced significant litigation and attorney fees amounting to 50.6 million yuan from January to September 2025, which impacted its net profit [10].

Core Viewpoint - Eddie Pharmaceuticals is expected to report a net profit loss of approximately 16 million to 24 million yuan for the fiscal year 2025, indicating a year-on-year reduction in loss margin by about 88.67% to 83% while continuing to record losses for five consecutive years [1] Financial Performance - The company has reported net profit losses of 29.99 million yuan, 124 million yuan, 76.07 million yuan, and 141 million yuan from 2021 to 2024 respectively [1] - The projected non-GAAP net loss for 2025 is estimated to be between 17.2 million and 25.2 million yuan, with a year-on-year reduction in loss margin of approximately 88.41% to 83.02% [1] - Expected operating revenue for 2025 is approximately 721 million yuan, representing a year-on-year increase of about 72.57% [1] Revenue Breakdown - Revenue from innovative anti-HIV drugs is anticipated to be 285 million yuan, reflecting a year-on-year increase of 90.34% [1] - Revenue from the subsidiary Nanda Pharmaceuticals is expected to reach 300 million yuan, with a year-on-year increase of 227.38% [1] Corporate Actions - The company plans to invest 130 million yuan to acquire an additional 22.23% stake in Nanda Pharmaceuticals, increasing its ownership from 51.1256% to 73.36% [3] - The acquisition price is based on an evaluation report, with the assessed value of the 22.23% stake being 130 million yuan, which is approximately 92% higher than its book net asset value of 200 million yuan [3] - This acquisition is seen as a strategic move to strengthen control over Nanda Pharmaceuticals and enhance the company's core competitiveness [3][4] Market Performance - As of January 23, the stock price of Eddie Pharmaceuticals rose by 2.59% to 18.64 yuan per share, with a total market capitalization of approximately 7.843 billion yuan [5] - The stock has seen a cumulative increase of about 157% over the past month [5]

Group 1 - Company plans to issue up to 300 million yuan in non-public bonds to professional investors, with the funds aimed at operational needs, debt repayment, and project investments [1] - Company has been experiencing declining performance, with revenues projected to drop to 2.495 billion yuan in 2023 and 2.324 billion yuan in 2024, while net losses are expected to worsen from 170 million yuan to 476 million yuan [3] - In response to ongoing losses, the company intends to sell a 49% stake in Dasheng Graphite for 206 million yuan to divest from underperforming assets [4][5] Group 2 - Dasheng Graphite, in which the company holds a 49% stake, reported revenues of 133 million yuan and a net loss of 38.27 million yuan in 2024, with further losses in 2025 [5] - The company aims to streamline operations and improve liquidity by divesting low-efficiency assets, aligning with its strategic focus on core business areas [5]

内蒙蒙牛所享有的该等债权，在并购基金所持长春市联鑫投资咨询有限公司(简称"长春联鑫")99.99%股权、长春联鑫所持吉林芝然乳品科技有限公司(简 称"吉林芝然")90%股权经拍卖或变卖后所得价款享有优先受偿权。内蒙蒙牛后续将根据该仲裁案件的执行情况、接管程序的落实情况，酌情依法申请强 制执行，包括但不限于可能通过启动对祥民基金所持长春联鑫99.99%股权、长春联鑫所持吉林芝然90%股权等担保物的拍卖、变卖程序实现债权清偿。 据了解，柴琇曾出具《关于并购基金相关事项的说明》并承诺： 由于并购基金上述担保事项导致公司面临直接或间接损失的(包括但不限于无法在合伙协议约定期限内足额、及时回收在并购基金中的出资及应得收益)， 其本人承诺将向公司足额补偿，并确保公司不至于因担保事项而出现损失。 1月25日，妙可蓝多（600882）公告，公司副董事长、总经理以及法定代表人柴琇离任，辞职后继续担任公司董事。 值得一提的是，柴琇离职的原因不是通常所见到的主动离职，而是"免职"，其还存在未履行完毕的公开承诺。 同时，公司聘任蒯玉龙为总经理，法定代表人亦相应变更为蒯玉龙，其不再兼任公司行政总经理。 | 妙可蓝多在公告中依然对柴琇表 ...